RxDoctor Payments Data

Joseph Chao, MD

Dermatology · San Francisco, CANPI 1861805210

Payments from drug & device makers

$16,932in general payments, 2019–2025

Across 490 payments — averaging $34.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Sanofi$2K
  • Galderma Laboratories, L.p.$1K
  • Almirall LLC$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Amgen$1000
  • plus $5K from 17 others
$1,200in research payments, 2019–2025

Across 1 payment — averaging $1200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1K

What the payments were for

  • Consulting fees$2,75016%
  • Food & beverage$13,89482%
  • Education$2882%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,932 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$221,010
Medicare patients
430
Services billed
1,958

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab57$297,645
Fluorouracil177$11,576
Calcipotriene60$10,156
Clobetasol Propionate86$3,627
Tacrolimus24$2,620
Betamethasone Dipropionate35$2,310
Metronidazole16$1,014
Triamcinolone Acetonide100$781
Ketoconazole65$743
Clindamycin Phosphate22$676
Ciclopirox18$349
Gabapentin12$179
Hydrocortisone30$99

Paid to pharmacies, not to this prescriber.

Other dermatology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →